av/neovacs--big.svg

COM:NEOVACS

Néovacs

  • Stock

EUR

Last Close

0.00

25/11 08:00

Market Cap

50.16K

Beta: -

Volume Today

9.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
29.88K
-
141.82K
374.65%
1.15M
709.45%
342.43K
70.17%
12.83K
96.25%
145K
1,029.81%
95.15K
34.38%
29.78K
68.70%
22.59K
24.14%
2.48K
89.03%
533.41K
21,417.22%
cost of revenue
547.58K
-
7.78M
1,321.22%
9.82M
26.17%
14.67M
49.36%
58.41K
99.60%
9.50M
16,157.70%
56.21K
99.41%
1.82M
3,146.24%
484.90K
73.42%
577.41K
19.08%
7.29M
1,162.15%
gross profit
-517.70K
-
-7.64M
1,375.85%
-8.67M
13.49%
-14.32M
65.19%
-45.58K
99.68%
-9.35M
20,417.45%
38.95K
100.42%
-1.79M
4,708.59%
-462.31K
74.24%
-574.93K
24.36%
-6.75M
1,074.81%
selling and marketing expenses
-13.07M
-
-5.67M
56.57%
-2.71M
52.17%
-1.16M
57.16%
general and administrative expenses
15.51M
-
9.17M
40.88%
5.13M
44.05%
1.60M
68.87%
4.08M
155.41%
selling general and administrative expenses
2.55M
-
1.92M
24.59%
2.40M
24.82%
2.67M
11.30%
2.44M
8.49%
3.50M
43.07%
2.42M
30.87%
434.49K
82.02%
4.08M
838.81%
-4.42M
-
research and development expenses
6.26M
-
7.80M
24.55%
10.68M
36.93%
14.66M
37.21%
16.48M
12.39%
10.59M
35.71%
5.87M
44.60%
1.20M
79.59%
4.47M
-
other expenses
7.38M
-
-136.16K
-
169.72K
224.65%
-79.36K
146.76%
70.19K
-
-65.89K
193.88%
3.35M
5,183.31%
6.20M
85.15%
-105.25K
101.70%
cost and expenses
7.93M
-
9.81M
23.78%
11.29M
15.09%
17.58M
55.71%
19.06M
8.37%
13.42M
29.60%
8.27M
38.36%
3.52M
57.40%
7.91M
124.64%
6.78M
14.34%
7.44M
9.77%
operating expenses
7.38M
-
2.03M
72.49%
1.47M
27.42%
2.92M
98.02%
19.00M
551.19%
10.59M
44.25%
8.21M
22.45%
1.70M
79.33%
7.43M
337.48%
6.20M
16.52%
153.19K
97.53%
interest expense
149.78K
-
163.10K
8.89%
68.81K
57.81%
99.46K
44.55%
509.31K
412.08%
473K
7.13%
106.89K
77.40%
2.00M
1,771.96%
364
99.98%
1.15M
316,878.57%
1.01M
12.75%
ebitda
-8.01M
-
-9.60M
19.97%
-11.23M
16.90%
-17.22M
53.43%
-19.00M
10.29%
-13.02M
31.49%
-8.21M
36.89%
-3.44M
58.15%
-9.53M
177.35%
-2.73M
71.42%
-6.74M
147.46%
operating income
-7.90M
-
-9.65M
22.23%
-11.28M
16.84%
-17.26M
53.04%
-19.06M
10.40%
-13.08M
31.36%
-8.27M
36.78%
-3.49M
57.76%
-7.83M
124.11%
-6.44M
17.67%
-6.91M
7.18%
depreciation and amortization
58.08K
-
49.63K
14.55%
52.14K
5.06%
36.42K
30.16%
58.41K
60.40%
64.14K
9.80%
56.21K
12.37%
55.18K
1.83%
-1.71M
3,192.94%
3.72M
317.97%
167.90K
95.49%
total other income expenses net
-119.86K
-
-164.91K
37.58%
4.03M
2,544.09%
-65.45K
101.62%
195.80K
399.16%
-475K
342.60%
-1.03M
117.30%
-3.19M
209.18%
-4.65M
45.73%
2.10M
145.14%
-2.71M
229.23%
income before tax
-8.02M
-
-9.82M
22.46%
-7.25M
26.18%
-17.33M
139.05%
-18.86M
8.85%
-13.55M
28.13%
-9.30M
31.38%
-6.68M
28.14%
-12.48M
86.69%
-4.35M
65.17%
-9.62M
121.36%
income tax expense
-1.15M
-
2.31M
300.88%
2.57M
11.27%
3.39M
32.31%
-4.02M
218.48%
-2.77M
31.00%
-1.75M
36.80%
-541.50K
69.12%
-641.05K
18.38%
-797.44K
24.40%
-876.76K
9.95%
net income
-6.87M
-
-7.51M
9.36%
-4.68M
37.67%
-13.93M
197.53%
-14.84M
6.50%
-10.78M
27.35%
-7.55M
29.98%
-6.14M
18.62%
-11.84M
92.71%
-3.55M
70.02%
-8.74M
146.40%
weighted average shs out
2.03K
-
2.36K
16.31%
3.30K
39.69%
1
-
248
-
3.52B
-
weighted average shs out dil
2.03K
-
2.36K
16.31%
3.30K
39.69%
1
-
248
-
3.52B
-
eps
-3.38K
-
-3.18K
5.97%
-1.42K
55.38%
-25.30M
1,781,462.87%
-17.14M
32.23%
-10.78M
37.12%
-3.83M
64.47%
-729.37K
80.96%
-47.73K
93.46%
0
100%
-0.00
Infinity%
epsdiluted
-3.38K
-
-3.18K
5.97%
-1.42K
55.38%
-25.30M
1,781,462.87%
-17.14M
32.23%
-10.78M
37.12%
-3.83M
64.47%
-729.37K
80.96%
-47.73K
93.46%
0
100%
-0.00
Infinity%

All numbers in EUR (except ratios and percentages)